Ryan Clarke
Ryan Clarke is the founding CEO of Syntax Bio and currently serving as the CTO. Ryan was trained as a developmental biologist with a specialty in CRISPR systems before launching Syntax, which has built an epigenetic programming system termed Cellgorithms for controlling stem cell fates for cell therapy applications.
Syntax Bio
AI 'Cheat Codes' Speed Therapeutic Cell Creation via Transcription Factors
-
One of the biggest challenges faced by the regenerative medicine field today is the ability to efficiently and scalably generate therapeutic cells. This session explores cutting-edge transcription factor-based approaches for rapid and efficient differentiation of stem cells into therapeutic cell types. We will examine how synthetic biology techniques are revolutionizing cell therapy by enabling faster production of clinically relevant cells. Speakers will discuss recent advances, challenges, and future directions in harnessing transcription factors for directed differentiation, with a focus on applications in regenerative medicine and drug discovery.
Conference Pass
2,495
USD
Keynotes & Firesides
Workshops & Breakouts
1:1 Partnering App
Meals & Receptions
Session Recordings
Until Friday April 18th
Full Rate:
$3,495